Current perspectives on common variable immunodeficiency (CVID)

[1]  R. Chapman,et al.  Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up , 1997, Clinical and experimental immunology.

[2]  A. Burks,et al.  Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. , 1986, The New England journal of medicine.

[3]  Marshall,et al.  Mannose Binding Lectin Polymorphisms are Associated With Early Age of Disease Onset and Autoimmunity in Common Variable Immunodeficiency , 2000, Scandinavian journal of immunology.

[4]  H. Kaneko,et al.  Abnormal B cell response of protein kinase C in some common variable immunodeficiency. , 1996, Experimental and clinical immunogenetics.

[5]  L. Hammarström,et al.  Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs , 1995, The Lancet.

[6]  G. C. Murray,et al.  A Report of Eight Cases and Review of the Literature , 1981 .

[7]  C. S. Scott,et al.  Abnormal CD45R expression in patients with common variable immunodeficiency and X‐linked agammaglobulinaemia , 1992, British journal of haematology.

[8]  J. V. van Meurs,et al.  Retinal vasculitis occurring with common variable immunodeficiency syndrome. , 2000, American journal of ophthalmology.

[9]  K. Welsh,et al.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. , 1997, Journal of immunology.

[10]  J. Farrant,et al.  Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). , 1994, Immunodeficiency.

[11]  J. Farrant,et al.  Splenic lesions in hypogammaglobulinaemia. , 1993, Advances in experimental medicine and biology.

[12]  Henry Levison,et al.  HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASE , 1987, The Lancet.

[13]  R S Chaganti,et al.  Non‐hodgkin lymphoma in common variable immunodeficiency , 1991, American journal of hematology.

[14]  A. Vecchione,et al.  Gastric pathology in patients with common variable immunodeficiency , 1999, Gut.

[15]  J. Farrant,et al.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. , 1989, Clinical and experimental immunology.

[16]  K. Sullivan,et al.  Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. , 1996, Medicine.

[17]  G. Spickett,et al.  Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy. , 1996, Journal of clinical pathology.

[18]  Raga,et al.  CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis , 1999, Clinical and experimental immunology.

[19]  E. Jaffe,et al.  Lymphoproliferative Lesions in Patients with Common Variable Immunodeficiency Syndrome , 1992, The American journal of surgical pathology.

[20]  J. Peto,et al.  PROSPECTIVE STUDY OF CANCER IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIA , 1985, The Lancet.

[21]  H. Chapel,et al.  Self-infusion with immunoglobulin at home. , 1991, Journal of clinical pathology.

[22]  J. Farrant,et al.  Failure in antigen responses by T ceils from patients with common variable immunodeficiency (CVID) , 1994, Clinical and experimental immunology.

[23]  J. Farrant,et al.  Common variable immunodeficiency: how many diseases? , 1997, Immunology today.

[24]  S. Patterson,et al.  Role of retroviruses in acquired hypogammaglobulinaemia. , 1988, Clinical and experimental immunology.

[25]  H. Chapel.  Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. , 1994, BMJ.

[26]  C. Brautbar,et al.  Common variable immunodeficiency: a family study and therapeutic trial with cimetidine. , 1989, The Journal of allergy and clinical immunology.

[27]  H. Herrod.  IgG subclass deficiency. , 1992, Allergy proceedings : the official journal of regional and state allergy societies.

[28]  Correction: Consensus on diagnosis and management of primary antibody deficiencies , 1994 .

[29]  D. Campana,et al.  Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia , 1998, The Journal of experimental medicine.

[30]  J. Gottsch,et al.  Bilateral consecutive central corneal perforations associated with hypogammaglobulinemia. , 2000, Ophthalmology.

[31]  P. Simmonds,et al.  Hepatitis C virus transmission by intravenous immunoglobulin. , 1994, Journal of hepatology.

[32]  J. Farrant,et al.  Cellular abnormalities in common variable immunodeficiency. , 1990, Immunodeficiency reviews.

[33]  Webster,et al.  Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon‐gamma (IFN‐γ) in CD28+ (‘cytotoxic’) and CD28− (‘suppressor’) CD8+ subsets , 1998, Clinical and experimental immunology.

[34]  C. Cunningham-Rundles,et al.  Hodgkin's disease associated with IgA and IgG subclass deficiency , 1996, Journal of internal medicine.

[35]  J. Farrant,et al.  Lymphocyte surface phenotype in common variable immunodeficiency. , 1992, Disease markers.

[36]  J. Seggev.  Spontaneous remission of common variable immunodeficiency of 20 years duration. , 1991, The Journal of allergy and clinical immunology.

[37]  P. Aukrust,et al.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features , 1992, Clinical and experimental immunology.

[38]  Martin L. Lee.  Intravenous Immunoglobulins in Clinical Practice , 1997 .

[39]  C. Cunningham-Rundles,et al.  Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2. , 1994, The New England journal of medicine.

[40]  Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis. , 1997, MMWR. Morbidity and mortality weekly report.

[41]  D. Campana,et al.  Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. , 1996, The New England journal of medicine.

[42]  J. Farrant,et al.  Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex , 1991, Clinical and experimental immunology.

[43]  D. Campana,et al.  An essential role for BLNK in human B cell development. , 1999, Science.

[44]  J. Farrant,et al.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. , 1990, Clinical immunology and immunopathology.

[45]  R. Hermaszewski,et al.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. , 1993, The Quarterly journal of medicine.

[46]  A. Durandy,et al.  CD40 ligand expression deficiency in a female carrier of the X‐linked hyper‐IgM syndrome as a result of X chromosome lyonization , 1999, European journal of immunology.

[47]  I. Caragol,et al.  Development of a common variable immunodeficiency in IgA-deficient patients. , 1996, Clinical immunology and immunopathology.

[48]  T. Peters,et al.  Serum neopterin patients with X-linked and acquired 'common variable' hypogammaglobulinaemia. , 1989, International Archives of Allergy and Applied Immunology.

[49]  J. Farrant,et al.  Defects in antigen‐driven lymphocyte responses in common variable immunodeficiency (CVID) are due to a reduction in the number of antigen‐specific CD4+ T cells , 1995, Clinical and experimental immunology.

[50]  J. Farrant,et al.  Raised serum levels of CD8, CD25 and β2‐microglobulin in common variable immunodeficiency , 1991, Clinical and experimental immunology.

[51]  Y. Hayashi,et al.  Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan , 1996, Human Genetics.

[52]  C. Cunningham-Rundles,et al.  Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.

[53]  H. Chapel,et al.  Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases. , 1995, Quality in health care : QHC.

[54]  C. Cunningham-Rundles,et al.  Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2. , 1992, Clinical immunology and immunopathology.

[55]  J. Farrant,et al.  Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C , 1991, Clinical and experimental immunology.

[56]  J. Volanakis,et al.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Nava,et al.  Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system , 1996, Clinical and experimental immunology.

[58]  G. Spickett,et al.  L‐selectin in patients with common variable immunodeficiency (CVID): a comparative study with normal individuals , 1996, Clinical and experimental immunology.

[59]  Lennart Hammarstrom,et al.  Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion , 1991, The Lancet.

[60]  T. Waldmann,et al.  Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. , 1990, Blood.

[61]  J. Farrant,et al.  Accessory and T cell defects in acquired and inherited hypogammaglobulinaemia. , 1989, Clinical and experimental immunology.

[62]  R. Shapiro,et al.  Lymphoproliferative disorders and other tumors complicating immunodeficiencies. , 1994, Immunodeficiency.

[63]  A. Plebani,et al.  Extensive deletion of immunoglobulin heavy chain constant region genes in the absence of recurrent infections: when is IgG subclass deficiency clinically relevant? , 1993, Clinical Immunology and Immunopathology.

[64]  P. Furr,et al.  Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. , 1997, British journal of rheumatology.

[65]  J. Farrant,et al.  Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti‐cytokine antibodies and three‐colour flow cytometry , 1996, Clinical and experimental immunology.